Grant, LR;
O'Brien, SE;
Burbidge, P;
Haston, M;
Zancolli, M;
Cowell, L;
Johnson, M;
... Goldblatt, D; + view all
(2013)
Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.
PLoS One
, 8
(9)
, Article e74906. 10.1371/journal.pone.0074906.
Preview |
PDF
journal.pone.0074906.pdf Download (293kB) |
Abstract
Protection against disease or colonization from serotypes related to those in pneumococcal conjugate vaccines (i.e. cross-protection) vary by serotype; the basis for this variation is not understood. The 13-valent pneumococcal conjugate vaccine (PCV13) replaced 7-valent conjugate (PCV7) in the USA in 2010 allowing assessment of PCV7 and PCV13 immunogenicity and functional cross-protection in vitro.
Archive Staff Only
View Item |